Jacobi P C, Dietlein T S, Krieglstein G K
University of Cologne, Department of Ophthalmology, Germany.
Graefes Arch Clin Exp Ophthalmol. 2000 Jul;238(7):545-51. doi: 10.1007/s004170000152.
This study was set up to establish the relative safety and effectiveness of trabecular aspiration in combination with phacoemulsification and intraocular lens (IOL) implantation (phacoaspiration) for decreasing intraocular pressure (IOP), and to compare the outcome of this method of treatment with that of standard filtering glaucoma triple procedure (phaco-trab).
Prospective, randomized study.
The study consisted of 40 eyes of 40 patients with uncontrolled exfoliation glaucoma without a history of previous intra- or extraocular surgery and in need of cataract surgery.
Temporal clear corneal phacoemulsification and foldable IOL implantation was performed in all eyes. In the phaco-aspiration group, trabecular aspiration was performed with a suction force of 100-200 mmHg under light tissue-instrument contact using a modified intraocular aspiration probe. A modified Cairns-type trabeculectomy without adjunctive antimetabolites was performed superiorly in the phaco-trab eyes after IOL implantation.
The surgical outcome was assessed in terms of IOP change, need for adjunctive glaucoma medication, visual acuity outcome, and incidence of complications.
At 1 year after combined surgery, mean (+/-SD) IOP and number of glaucoma medi- cation were 19.5+/-2.7 mmHg and 0.6+/-0.5 in the phaco-aspiration group, compared with 17.5+/-2.4 mmHg and 0.3+/-0.4 in the phaco-trab group. Hyphema (38%) and ocular hypotony (14%) were observed in the phaco-trab group only, whereas blood reflux (52%) and descemetolyses (23%) were seen exclusively in the phaco-aspiration group.
In exfoliative eyes, trabecular aspiration in combination with phacoemulsification and IOL implantation is less effective in reducing postoperative IOP and number of glaucoma medications than the standard filtering glaucoma triple procedure. The risk profile, however, appears to be more favorable in the phaco-aspiration-treated eyes than in the phaco-trab group. Trabecular aspiration in glaucoma triple procedure could serve as a possible treatment of choice for exfoliative eyes with coexisting cataract and glaucoma.
本研究旨在确定小梁抽吸联合超声乳化白内障吸除术及人工晶状体(IOL)植入术(超声乳化抽吸术)降低眼压(IOP)的相对安全性和有效性,并将该治疗方法的结果与标准青光眼三联滤过手术(超声乳化小梁切除术)的结果进行比较。
前瞻性随机研究。
本研究纳入40例患者的40只眼,这些患者患有未控制的剥脱性青光眼,无眼内或眼外手术史且需要进行白内障手术。
所有患眼均行颞侧透明角膜超声乳化白内障吸除术及折叠式IOL植入术。在超声乳化抽吸组中,使用改良的眼内抽吸探头,在轻柔的组织 - 器械接触下,以100 - 200 mmHg的吸力进行小梁抽吸。在超声乳化小梁切除组中,IOL植入术后在上方行改良的Cairns型小梁切除术,不使用辅助抗代谢药物。
根据眼压变化、辅助青光眼药物的需求、视力结果和并发症发生率评估手术效果。
联合手术后1年,超声乳化抽吸组的平均(±标准差)眼压和青光眼药物使用次数分别为19.5±2.7 mmHg和0.6±0.5,而超声乳化小梁切除组分别为17.5±2.4 mmHg和0.3±0.4。仅在超声乳化小梁切除组观察到前房积血(38%)和低眼压(14%),而仅在超声乳化抽吸组观察到血液反流(52%)和后弹力层脱离(23%)。
在剥脱性青光眼眼中,小梁抽吸联合超声乳化白内障吸除术及IOL植入术在降低术后眼压和减少青光眼药物使用次数方面不如标准青光眼三联滤过手术有效。然而,超声乳化抽吸治疗的患眼的风险状况似乎比超声乳化小梁切除组更有利。青光眼三联手术中的小梁抽吸可作为患有白内障和青光眼的剥脱性青光眼眼的一种可能的治疗选择。